Navigation Links
New research questions basic tenet of neuron function

New findings by researchers at UT Southwestern Medical Center challenge one of the established views of how nerve cells communicate with one another.

Every time we move, feel emotions, think or remember, the nerve cells, or neurons, in our body transmit messages to one another via chemical signals called neurotransmitters. Within neurons are tiny organelles called synaptic vesicles that sequester neurotransmitters and release them when needed into the synapse, or space between nerve cells, where the chemical signal is transmitted to other neurons.

It is known that synaptic vesicles release their neurotransmitters in two different "modes" ?one when the neuron is stimulated and actively relaying a message, and the other through spontaneous release when the neuron is "at rest," or inactive. Until now it was believed that the same synaptic vesicles were responsible for releasing neurotransmitters in both modes.

However, new research by UT Southwestern scientists appearing in the Feb. 17 issue of the journal Neuron suggests that two distinct types of synaptic vesicles are responsible for the two different modes of neurotransmitter release ?one type of vesicle for spontaneous release, another vesicle associated with activity-dependent release.

"These findings question one of the core tenets of synaptic function and reveal significant complexity in organization of synaptic vesicles within individual synapses," said Dr. Ege Kavalali, assistant professor in the Center for Basic Neuroscience and of physiology at UT Southwestern and senior author on the study.

Neurotransmitters regulate many different aspects of mood, cognition and behavior, such as emotional state, reactions to stress, pain, and the physical drives of sleep, appetite and sexuality.

A better understanding of such fundamental mechanisms of neurotransmitter release will aid researchers in their investigations of psychiatric disorders and neurological disorder
'"/>

Source:UT Southwestern


Page: 1 2

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. U of M researcher examines newly emerging deadly disease
3. NYU researchers simulate molecular biological clock
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. Vital step in cellular migration described by UCSD medical researchers
6. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
7. UCSD researchers maintain stem cells without contaminated animal feeder layers
8. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
9. New protein discovered by Hebrew University researchers
10. First real-time view of developing neurons reveals surprises, say Stanford researchers
11. New research indicates a troubled greenhouse is brewing

Post Your Comments:
(Date:11/4/2009)...t,s the cost of saving a teenage life? When it com...rescription medication abuse, there,s no price tag...aware that the lock-boxes they,ve installed are no... of prescription drugs. That,s why MEDNET(TM), a n..., has formed an exclusive partnership with Axius H...
(Date:11/4/2009)...l/ -- BIO-key International, Inc. (OTC Bulletin Bo...ntification software is showcasing donor and patie...being held at the New Orleans Convention Center fr...on product demonstrations of its state-of-the-art ...5 PM on Monday, October 26, Peter Lux, manager of ...
(Date:11/4/2009)...sity of North Carolina at Chapel Hill School of Me...isco have developed and experimentally tested a te...g drugs. , The researchers developed a computati...es of all known drugs are to the naturally occurri...ase targets within the cell. In a study published ...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Study points to new uses, unexpected side effects of already existing drugs 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 1Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 3Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 4Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4
...erta has helped map out the animal,s life span and...species lived, says new research conducted in part...rises to me was that the overall pattern of surviv...than the catastrophic model we were expecting," sa...e and professor in the U of A,s Department of Biol...
...eceptors in breast cancer may play a role in resis...xifen treatment, according to a study in the May 1...Pak 1 is a member of a family of proteins involved...cell movement, and cell death. Previous studies h...y lead to more invasive breast cancer. , Goran ...
...nsible for singing and mating are shrinking when e...of Alberta research--the first proof that natural ...ild animal. , "These residues have been persisti...turbing," said Dr. Andrew Iwaniuk, a post-doctoral...chology. "It has been years since it has been used...
Other Biology News:Tyrannosaur survivorship -- tough times for teens 2Pak1 expression increases tamoxifen resistance in breast cancer patients 2Bird brains shrink from exposure to contaminants 2
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...
(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...ced today,that the company initiated its pivotal P...tucel-L) in the treatment of advanced non-small ce... in the study was treated by,Dr. Lyudmila Bazhenov...sity,of California, San Diego School of Medicine.,...80821/LATH009-a ), (Photo: http://www.newscom.co...
...nderlying Cause of Cystic,Fibrosis; Oral Drug May ...ELD, N.J., Aug. 20 New phase 2 data,published tod...l drug,PTC124 demonstrates activity in nonsense-mu...eatment with PTC124 results in statistically signi...on of patients with,nonsense-mutation CF. The stud...
...ystems,(MMS) today announced a new partnership wit... the result of a legislative initiative that,estab...h benefit for North,Dakota state employees and oth...nce Pharmaceutical Care System(TM) will provide No...aining and technology to guide and,document the de...
Other Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 2PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 3PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 5North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
...are designed to rapidly and reliably amplify unkno... APAgene provides hassle-free, ready-to use compon... necessary ingredients are provided in each kit. T...t-end amplification of large clones such as P1, YA...
Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam
...is designed to deparaffinize and perform Heat Indu...affin-embedded tissue sections mounted on glass mi...by melting the paraffin at the high temperature us...ation of the paraffin by detergent. Formaldehyde f...
Biology Products: